Teladoc Health (NYSE:TDOC) Reaches New 1-Year Low at $12.36

Shares of Teladoc Health, Inc. (NYSE:TDOC) hit a new 52-week low on Wednesday . The company traded as low as $12.36 and last traded at $12.38, with a volume of 954796 shares trading hands. The stock had previously closed at $12.88.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the company. Leerink Partnrs reiterated a “market perform” rating on shares of Teladoc Health in a research report on Monday, February 26th. Citigroup dropped their target price on shares of Teladoc Health from $21.00 to $19.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 21st. Piper Sandler reduced their price target on shares of Teladoc Health from $30.00 to $25.00 and set an “overweight” rating for the company in a research report on Wednesday, February 21st. Canaccord Genuity Group reduced their target price on Teladoc Health from $28.00 to $25.00 and set a “buy” rating for the company in a report on Friday, April 26th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Teladoc Health in a research report on Friday, April 26th. Twelve investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $18.73.

Teladoc Health Trading Up 0.2 %

The company has a current ratio of 3.82, a quick ratio of 3.74 and a debt-to-equity ratio of 0.67. The company has a market cap of $2.07 billion, a PE ratio of -8.67 and a beta of 0.97. The company has a fifty day simple moving average of $14.20 and a two-hundred day simple moving average of $17.36.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Thursday, April 25th. The health services provider reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.47) by ($0.02). The firm had revenue of $646.13 million for the quarter, compared to analysts’ expectations of $637.31 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.90%. Teladoc Health’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same period last year, the firm posted ($0.37) earnings per share. Analysts anticipate that Teladoc Health, Inc. will post -1.04 EPS for the current year.

Insider Activity at Teladoc Health

In other news, EVP Andrew Turitz sold 6,190 shares of Teladoc Health stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $89,878.80. Following the sale, the executive vice president now directly owns 39,429 shares of the company’s stock, valued at $572,509.08. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other Teladoc Health news, EVP Andrew Turitz sold 6,190 shares of the company’s stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $14.52, for a total value of $89,878.80. Following the completion of the sale, the executive vice president now directly owns 39,429 shares in the company, valued at $572,509.08. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Daniel Trencher sold 6,780 shares of Teladoc Health stock in a transaction on Monday, March 4th. The shares were sold at an average price of $14.52, for a total value of $98,445.60. Following the transaction, the insider now owns 28,192 shares in the company, valued at $409,347.84. The disclosure for this sale can be found here. Insiders sold a total of 138,368 shares of company stock valued at $1,989,227 over the last ninety days. Insiders own 0.95% of the company’s stock.

Hedge Funds Weigh In On Teladoc Health

Hedge funds have recently made changes to their positions in the business. Commonwealth Equity Services LLC increased its holdings in shares of Teladoc Health by 5.7% in the third quarter. Commonwealth Equity Services LLC now owns 80,934 shares of the health services provider’s stock valued at $1,505,000 after buying an additional 4,344 shares in the last quarter. Raymond James & Associates raised its holdings in Teladoc Health by 0.9% during the 3rd quarter. Raymond James & Associates now owns 228,238 shares of the health services provider’s stock worth $4,243,000 after buying an additional 2,029 shares during the period. Mackenzie Financial Corp boosted its holdings in shares of Teladoc Health by 83.7% in the third quarter. Mackenzie Financial Corp now owns 30,843 shares of the health services provider’s stock worth $570,000 after buying an additional 14,050 shares during the period. Allspring Global Investments Holdings LLC raised its holdings in shares of Teladoc Health by 8.8% during the third quarter. Allspring Global Investments Holdings LLC now owns 50,903 shares of the health services provider’s stock valued at $946,000 after acquiring an additional 4,129 shares during the period. Finally, Triumph Capital Management purchased a new stake in shares of Teladoc Health in the 3rd quarter valued at approximately $320,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.